HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The bone scan in patients with aluminium-associated bone disease.

Abstract
The bone scans of 32 patients on regular dialysis who received desferrioxamine therapy for fracturing osteomalacia secondary to aluminium intoxication are reviewed. All scans show the same pattern, with lack of tracer deposition in bone and deposition in soft tissues. Therapy with desferrioxamine controlled the aluminium intoxication in all cases, and in 21 patients the bone scan reverted to normal or showed a pattern typical of hyperparathyroidism.
AuthorsJ Botella, J L Gallego, J Fernandez-Fernandez, D Sanz-Guajardo, A de Miguel, J Ramos, P Franco, R Enriques, C Sanz-Moreno
JournalProceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress (Proc Eur Dial Transplant Assoc Eur Ren Assoc) Vol. 21 Pg. 403-9 ( 1985) England
PMID3991532 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Aluminum
  • Deferoxamine
Topics
  • Aluminum (adverse effects)
  • Deferoxamine (therapeutic use)
  • Humans
  • Hyperparathyroidism, Secondary (diagnostic imaging)
  • Osteomalacia (diagnostic imaging)
  • Radionuclide Imaging
  • Renal Dialysis (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: